Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
65.75
-0.95 (-1.42%)
Mar 31, 2025, 1:12 PM EDT - Market open
Belite Bio Employees
Belite Bio had 25 employees as of December 31, 2024. The number of employees increased by 5 or 25.00% compared to the previous year.
Employees
25
Change (1Y)
5
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,445,760
Market Cap
2.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25 | 5 | 25.00% |
| Dec 31, 2023 | 20 | 4 | 25.00% |
| Dec 31, 2022 | 16 | 4 | 33.33% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BLTE News
- 13 days ago - Belite Bio, Inc. (BLTE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website - GlobeNewsWire
- 14 days ago - Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 20 days ago - Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 7 weeks ago - Belite Bio Announces Registered Direct Offering of $15 Million - GlobeNewsWire
- 4 months ago - Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 - GlobeNewsWire
- 4 months ago - Belite Bio, Inc. (BLTE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results - GlobeNewsWire